NCT01979523 2026-03-19Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting42 enrolled 13 charts
NCT01328106 2017-12-12Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal MelanomaGlaxoSmithKlinePhase 2 Withdrawn